The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Age-related Eye Disease Study 2 (AREDS2)
Open accessAbstract
Purpose The Age-Related Eye Disease Study (AREDS) demonstrated beneficial effects of oral supplementation with antioxidant vitamins and minerals on the development of advanced age-related macular degeneration (AMD) in persons with at least intermediate AMD (bilateral large drusen with or without pigment changes). Observational data suggest that other oral nutrient supplements might further reduce the risk of progression to advanced AMD. The primary purpose of Age-Related Eye Disease Study 2 (AREDS2) is to evaluate the efficacy and safety of lutein+zeaxanthin (L+Z) and/or omega-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation in reducing the risk of developing advanced AMD. The study will also assess the reduction in zinc and the omission of beta-carotene from original AREDS formulation. Design Multicenter phase 3 randomized controlled clinical trial Participants Persons age 50 to 85 with bilateral intermediate AMD or advanced AMD in one eye Methods All participants were randomly assigned to: 1) placebo (n=1012); 2) L+Z (10 mg/2 mg, n=1044); 3) ω-3 LCPUFAs (eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) [650gmg/350 mg] n=1069); or 4) the combination of L+Z and ω -3 LCPUFAs (n=1078). All participants were offered a secondary randomization to 1 of 4 variations of the original AREDS formulation keeping vitamins C (500 mg), E (400 IU), and copper (2 mg) unchanged while varying zinc and beta-carotene as follows: zinc remains at the original level (80mg), lower only zinc to 25mg, omit beta-carotene only, or lower zinc to 25 mg and omit beta-carotene. Main Outcome Measures Progression to advanced AMD determined by centralized grading of annual fundus photographs. Results 4,203 participants were enrolled at 82 clinical centers located in the U.S. Population characteristics at baseline were as follows: mean age 74 years, 57% female, 97% white, 7% current smokers, 19% with prior cardiovascular disease and 44% and 50% taking statin-class cholesterol lowering drugs and aspirin, respectively. Ocular characteristics include 59% with bilateral large drusen, 32% with advanced AMD in one eye and mean visual acuity of 20/32 in eyes without advanced AMD. Conclusion This report presents the AREDS2 study design and the participants’ baseline demographic and ocular characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trumbo (2001) · doi:10.1016/s0002-8223(01)00078-5 · Cited by 4,852
(2001) · National Academies Press eBooks · doi:10.17226/10026 · Cited by 3,023
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Regression analysis of multivariate incomplete failure time data by modeling marginal distributions
Wei, L. J., Lin, D. Y., & Weissfeld, L. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478873 · Cited by 1,868
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1550 · Cited by 1,255
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
Seddon, J. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520180037032 · Cited by 993
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
SanGiovanni, J. P., & Chew, E. Y. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.002 · Cited by 874
Self-citationLutein, Zeaxanthin, and the Macular Pigment
Landrum, J. T., & Bone, R. A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2171 · Cited by 818
A Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 18
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1570 · Cited by 807
B IOLOGIC M ECHANISMS OF THE P ROTECTIVE R OLE OF L UTEIN AND Z EAXANTHIN IN THE E YE
Krinsky, N. I., Landrum, J. T., & Bone, R. A. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073307 · Cited by 779
Prevalence of Cataract and Pseudophakia/Aphakia Among Adults in theUnited States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.487 · Cited by 577
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.9.1225 · Cited by 434
Seddon, J. M. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.7.995 · Cited by 415
Dietary fat and risk for advanced age-related macular degeneration
Seddon, J. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.8.1191 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1728 · Cited by 384
Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration
Tan, J. S. L., Wang, J. J., Flood, V., Rochtchina, E., Smith, W., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.083 · Cited by 381
Encyclopedia of Dietary Supplements
(2010) · CRC Press eBooks · doi:10.1201/b14669 · Cited by 380
Albanes, D., Heinonen, O., Huttunen, J., Taylor, P., Virtamo, J., Edwards, B., Haapakoski, J., Rautalahti, M., Hartman, A., & Palmgren, J. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1427s · Cited by 379
Oral Zinc in Macular Degeneration
Newsome, D. A., Swartz, M., Leone, N. C., Elston, R. C., & Miller, E. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060130202026 · Cited by 349
Antioxidant status and neovascular age-related macular degeneration
(1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090010108035 · Cited by 304
Marse-Perlman, J. A., Fisher, A. I., Klein, R., Palta, M., Block, G., Millen, A. E., & Wright, J. D. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.5.424 · Cited by 286
Delcourt, C., Carrie`re, I., Delage, M., Barberger-Gateau, P., & Schalch, W. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1235 · Cited by 257
Moeller, S. M. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.8.1151 · Cited by 255
Antioxidant Intake and Risk of Incident Age-related Nuclear Cataracts In the Beaver Dam Eye Study
Lyle, B. J., Mares-Perlman, J. A., Klein, B. E. K., Klein, R., & Greger, J. L. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009895 · Cited by 220
SanGiovanni, J. P. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.9.1274 · Cited by 206
Self-citationMeasurement of carotenoids, retinoids, and tocopherols in human lenses.
Yeum, K., Taylor, A., Tang, G., & Russell, R. M. (1995) · PubMed · Cited by 204
SanGiovanni, J. P., Agrón, E., Meleth, A. D., Reed, G. F., Sperduto, R. D., Clemons, T. E., & Chew, E. Y. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27594 · Cited by 186
Self-citationAugood, C., Chakravarthy, U., Young, I., Vioque, J., de Jong, P. T., Bentham, G., Rahu, M., Seland, J., Soubrane, G., Tomazzoli, L., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.2.398 · Cited by 176
Dietary fatty acids and the 5-year incidence of age-related maculopathy
Chua, B. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.7.981 · Cited by 172
Neovascular age-related macular degeneration and its relationship to antioxidant intake
Snellen, E. L. M., Verbeek, A. L. M., Van Den Hoogen, G. W. P., Cruysberg, J. R. M., & Hoyng, C. B. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800404.x · Cited by 137
Moeller, S. M. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.3.354 · Cited by 123
Dherani, M., Murthy, G. V. S., Gupta, S., Young, I. S., Maraini, G., Camparini, M., Price, G. M., John, N., Chakravarthy, U., & FLETCHER, A. E. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1202 · Cited by 102
Chitchumroonchokchai, C., Bomser, J. A., Glamm, J. E., & Failla, M. L. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3225 · Cited by 83
Lutein and Zeaxanthin and the Risk of Cataract: The Melbourne Visual Impairment Project
Vu, H. T., Robman, L. D., Hodge, A. M., McCarty, C. A., & Taylor, H. R. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0587 · Cited by 78
SanGiovanni, J. P., Agrón, E., Clemons, T. E., & Chew, E. Y. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2008.518 · Cited by 75
Self-citationLutein prevents cataract development and progression in diabetic rats
Arnal, E., Miranda, M., Almansa, I., Muriach, M., Barcia, J. M., Romero, F. J., Díaz-Llopis, M., & Bosch‐Morell, F. (2008) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-0935-z · Cited by 73
The Impact of Fish and Shellfish Consumption on Age-Related Macular Degeneration
Swenor, B. K., Bressler, S. B., Caulfield, L. E., & West, S. K. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.03.058 · Cited by 53
Underwood Memorial LectureHuman Zinc Homeostasis: Good but Not Perfect
Hambidge, M. (2003) · Journal of Nutrition · doi:10.1093/jn/133.5.1438s · Cited by 34
Lutein and Age-Related Ocular Disorders in the Older Adult: A Review
Renzi‐Hammond, L. M., & Johnson, E. J. (2007) · Journal of Nutrition for the Elderly · doi:10.1300/j052v26n03_07 · Cited by 26
Cited by
Algorithmic fairness in artificial intelligence for medicine and healthcare
Chen, R. J., Wang, J. J., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Lu, M. Y., Sahai, S., & Mahmood, F. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01056-8 · Cited by 750
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7376 · Cited by 415
Self-citationOmega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Metadata
- Authors
- Chew, E. Y., Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., Sperduto, R., & Ferris, F. L.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 119
- Issue
- 11
- Pages
- 2282-2289
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2154864949
- Cited by
- 415
- References
- 43
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.